84 related articles for article (PubMed ID: 21475617)
41. Spatial Variation of Survival for Colorectal Cancer in Malaysia.
Ghazali AK; Keegan T; Taylor BM
Int J Environ Res Public Health; 2021 Jan; 18(3):. PubMed ID: 33503972
[TBL] [Abstract][Full Text] [Related]
42. Spatially varying effects of predictors for the survival prediction of nonmetastatic colorectal Cancer.
Tian Y; Li J; Zhou T; Tong D; Chi S; Kong X; Ding K; Li J
BMC Cancer; 2018 Nov; 18(1):1084. PubMed ID: 30409119
[TBL] [Abstract][Full Text] [Related]
43. Do African American Patients Treated with Radical Cystectomy for Bladder Cancer have Worse Overall Survival? Accounting for Pathologic Staging and Patient Demographics Beyond Race Makes a Difference.
Kaye DR; Canner JK; Kates M; Schoenberg MP; Bivalacqua TJ
Bladder Cancer; 2016 Apr; 2(2):225-234. PubMed ID: 27376141
[No Abstract] [Full Text] [Related]
44. Seasonal and geographical variations in lung cancer prognosis in Norway. Does Vitamin D from the sun play a role?
Porojnicu AC; Robsahm TE; Dahlback A; Berg JP; Christiani D; Bruland OS; Moan J
Lung Cancer; 2007 Mar; 55(3):263-70. PubMed ID: 17207891
[TBL] [Abstract][Full Text] [Related]
45. Racial disparities in stage-specific gastric cancer: analysis of results from the Surveillance Epidemiology and End Results (SEER) program database.
Zhang G; Zhao X; Li J; Yuan Y; Wen M; Hao X; Li P; Zhang A
J Investig Med; 2017 Aug; 65(6):991-998. PubMed ID: 28442533
[TBL] [Abstract][Full Text] [Related]
46. Application of a novel machine learning framework for predicting non-metastatic prostate cancer-specific mortality in men using the Surveillance, Epidemiology, and End Results (SEER) database.
Lee C; Light A; Alaa A; Thurtle D; van der Schaar M; Gnanapragasam VJ
Lancet Digit Health; 2021 Mar; 3(3):e158-e165. PubMed ID: 33549512
[TBL] [Abstract][Full Text] [Related]
47. A Bayesian Semiparametric Temporally-Stratified Proportional Hazards Model with Spatial Frailties.
Hanson TE; Jara A; Zhao L
Bayesian Anal; 2011; 6(4):1-48. PubMed ID: 22247752
[TBL] [Abstract][Full Text] [Related]
48. Spatial Survival Model for COVID-19 in México.
Pérez-Castro E; Guzmán-Martínez M; Godínez-Jaimes F; Reyes-Carreto R; Vargas-de-León C; Aguirre-Salado AI
Healthcare (Basel); 2024 Jan; 12(3):. PubMed ID: 38338191
[TBL] [Abstract][Full Text] [Related]
49. Spatial-temporal Bayesian accelerated failure time models for survival endpoints with applications to prostate cancer registry data.
Wang M; Li Z; Lu J; Zhang L; Li Y; Zhang L
BMC Med Res Methodol; 2024 Apr; 24(1):86. PubMed ID: 38589783
[TBL] [Abstract][Full Text] [Related]
50. Understanding the role of environmental and socioeconomic factors in the geographic variation of breast cancer risk in the US-wide Sister Study.
Carroll R; Ish JL; Sandler DP; White AJ; Zhao S
Environ Res; 2023 Dec; 239(Pt 1):117349. PubMed ID: 37821066
[TBL] [Abstract][Full Text] [Related]
51. The Spatial-Temporal Dimension of Oncological Prevalence and Mortality in Romania.
Peptenatu D; Nedelcu ID; Pop CS; Simion AG; Furtunescu F; Burcea M; Andronache I; Radulovic M; Jelinek HF; Ahammer H; Gruia AK; Grecu A; Popa MC; Militaru V; Drăghici CC; Pintilii RD
Geohealth; 2023 Oct; 7(10):e2023GH000901. PubMed ID: 37799773
[TBL] [Abstract][Full Text] [Related]
52. The Evaluation of Survival Rate in Patients with Prostate Cancer by Bayesian Weibull Parametric Accelerated Failure-Time Model.
Askari Tajabadi N; Pakmanesh H; Mirzaee M; Jahani Y
Iran J Public Health; 2022 Sep; 51(9):2108-2116. PubMed ID: 36743368
[TBL] [Abstract][Full Text] [Related]
53. Bayesian Spatial Survival Analysis of Duration to Cure among New Smear-Positive Pulmonary Tuberculosis (PTB) Patients in Iran, during 2011-2018.
Nazar E; Baghishani H; Doosti H; Ghavami V; Aryan E; Nasehi M; Sharafi S; Esmaily H; Yazdani Charati J
Int J Environ Res Public Health; 2020 Dec; 18(1):. PubMed ID: 33374751
[No Abstract] [Full Text] [Related]
54. Bayesian cure-rate survival model with spatially structured censoring.
Onicescu G; Lawson AB
Spat Stat; 2018 Dec; 28():352-364. PubMed ID: 32855903
[TBL] [Abstract][Full Text] [Related]
55. Spatial patterns in prostate Cancer-specific mortality in Pennsylvania using Pennsylvania Cancer registry data, 2004-2014.
Wang M; Wasserman E; Geyer N; Carroll RM; Zhao S; Zhang L; Hohl R; Lengerich EJ; McDonald AC
BMC Cancer; 2020 May; 20(1):394. PubMed ID: 32375682
[TBL] [Abstract][Full Text] [Related]
56. Spatially-explicit survival modeling with discrete grouping of cancer predictors.
Onicescu G; Lawson AB; Zhang J; Gebregziabher M; Wallace K; Eberth JM
Spat Spatiotemporal Epidemiol; 2019 Jun; 29():139-148. PubMed ID: 31128623
[TBL] [Abstract][Full Text] [Related]
57. Spatially explicit survival modeling for small area cancer data.
Onicescu G; Lawson A; Zhang J; Gebregziabher M; Wallace K; Eberth JM
J Appl Stat; 2018; 45(3):568-585. PubMed ID: 30906096
[TBL] [Abstract][Full Text] [Related]
58. Trends in Colorectal Cancer Incidence and Survival in Iowa SEER Data: The Timing of It All.
Carroll R; Zhao S
Clin Colorectal Cancer; 2019 Jun; 18(2):e261-e274. PubMed ID: 30713133
[TBL] [Abstract][Full Text] [Related]
59. Bayesian inference in time-varying additive hazards models with applications to disease mapping.
Chernoukhov A; Hussein A; Nkurunziza S; Bandyopadhyay D
Environmetrics; 2018; 29(5-6):. PubMed ID: 30510463
[TBL] [Abstract][Full Text] [Related]
60. Temporally dependent accelerated failure time model for capturing the impact of events that alter survival in disease mapping.
Carroll R; Lawson AB; Zhao S
Biostatistics; 2019 Oct; 20(4):666-680. PubMed ID: 29939209
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
